SENP1

Across TCGA pan-cancer cohorts, SENP1 Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated SENP1 data layer compared with 26 for mass-spec protein and 5 for mass-spec protein.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher SENP1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated SENP1 expression acts as an unfavorable survival marker, although some lineages such as BLCA show a favorable association.

STAD, BRCA, and PRAD are the cancer types where SENP1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Median	All	0.152	0.567	.010	18	view →
BRCA	OS	Median	IV	0.106	0.791	<.001	14	view →
PRAD	DFS	Median	All	0.153	0.888	<.001	6	view →
BLCA	DFS	Median	III,IV	1.000	0.271	.040	2	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

SENP1–STAD (OS)

Open the STAD breakdown →